BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9188490)

  • 1. Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression.
    Andersen B; Hariri A; Pittelkow MR; Rosenfeld MG
    J Biol Chem; 1997 Jun; 272(25):15905-13. PubMed ID: 9188490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The POU domain factor Skin-1a represses the keratin 14 promoter independent of DNA binding. A possible role for interactions between Skn-1a and CREB-binding protein/p300.
    Sugihara TM; Kudryavtseva EI; Kumar V; Horridge JJ; Andersen B
    J Biol Chem; 2001 Aug; 276(35):33036-44. PubMed ID: 11429405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation.
    Andersen B; Weinberg WC; Rennekampff O; McEvilly RJ; Bermingham JR; Hooshmand F; Vasilyev V; Hansbrough JF; Pittelkow MR; Yuspa SH; Rosenfeld MG
    Genes Dev; 1997 Jul; 11(14):1873-84. PubMed ID: 9242494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.
    Yukawa K; Butz K; Yasui T; Kikutani H; Hoppe-Seyler F
    J Virol; 1996 Jan; 70(1):10-6. PubMed ID: 8523512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skn-1a and Skn-1i: two functionally distinct Oct-2-related factors expressed in epidermis.
    Andersen B; Schonemann MD; Flynn SE; Pearse RV; Singh H; Rosenfeld MG
    Science; 1993 Apr; 260(5104):78-82. PubMed ID: 7682011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functional interactions of human Skn-1 isoforms with Ese-1 during keratinocyte terminal differentiation.
    Cabral A; Fischer DF; Vermeij WP; Backendorf C
    J Biol Chem; 2003 May; 278(20):17792-9. PubMed ID: 12624109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the regulatory domains of the human skn-1a/Epoc-1/Oct-11 POU transcription factor.
    Hildesheim J; Foster RA; Chamberlin ME; Vogel JC
    J Biol Chem; 1999 Sep; 274(37):26399-406. PubMed ID: 10473598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor.
    Kakizawa T; Miyamoto T; Ichikawa K; Takeda T; Suzuki S; Mori J; Kumagai M; Yamashita K; Hashizume K
    J Biol Chem; 2001 Mar; 276(13):9720-5. PubMed ID: 11134019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells.
    Yukawa K; Yasui T; Yamamoto A; Shiku H; Kishimoto T; Kikutani H
    Gene; 1993 Nov; 133(2):163-9. PubMed ID: 8224904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression.
    Lena AM; Cipollone R; Amelio I; Catani MV; Ramadan S; Browne G; Melino G; Candi E
    Biochem Biophys Res Commun; 2010 Oct; 401(4):568-73. PubMed ID: 20888799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human involucrin promoter activity by POU domain proteins.
    Welter JF; Gali H; Crish JF; Eckert RL
    J Biol Chem; 1996 Jun; 271(25):14727-33. PubMed ID: 8663077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segments of the POU domain influence one another's DNA-binding specificity.
    Aurora R; Herr W
    Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor human Skn-1a enhances replication of human papillomavirus DNA through the direct binding to two sites near the viral replication origin.
    Kukimoto I; Mori S; Sato H; Takeuchi T; Kanda T
    FEBS J; 2008 Jun; 275(12):3123-35. PubMed ID: 18479461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the transactivation domain of the Oct-6 POU transcription factor.
    Meijer D; Graus A; Grosveld G
    Nucleic Acids Res; 1992 May; 20(9):2241-7. PubMed ID: 1594443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
    González MI; Tovaglieri A; Robins DM
    Mol Cell Endocrinol; 2002 Apr; 190(1-2):39-49. PubMed ID: 11997177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.
    Préfontaine GG; Walther R; Giffin W; Lemieux ME; Pope L; Haché RJ
    J Biol Chem; 1999 Sep; 274(38):26713-9. PubMed ID: 10480874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain.
    Verrijzer CP; Kal AJ; van der Vliet PC
    Genes Dev; 1990 Nov; 4(11):1964-74. PubMed ID: 1980478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
    Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
    J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells.
    Morris PJ; Dent CL; Ring CJ; Latchman DS
    Nucleic Acids Res; 1993 Feb; 21(4):1019-23. PubMed ID: 8383834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation.
    Beck IM; Müller M; Mentlein R; Sadowski T; Mueller MS; Paus R; Sedlacek R
    J Invest Dermatol; 2007 May; 127(5):1107-14. PubMed ID: 17195013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.